These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 27160541)

  • 1. Biomarkers-based personalized follow-up in chronic heart failure improves patient's outcomes and reduces care associate cost.
    Leon-Justel A; Morgado Garcia-Polavieja JI; Alvarez-Rios AI; Caro Fernandez FJ; Merino PAP; Galvez Rios E; Vazquez-Rico I; Diaz Fernandez JF
    Health Qual Life Outcomes; 2021 May; 19(1):142. PubMed ID: 33964944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining a path toward improved heart failure care.
    Desai NR; Clark KAA
    Am J Manag Care; 2023 Sep; 29(10 Suppl):S195-S200. PubMed ID: 37677744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Holding the Readmission Gates: Incentivizing Quality and Cost-Effective Care for Heart Failure.
    Fonarow GC; Ziaeian B
    JACC Heart Fail; 2017 Aug; 5(8):589-590. PubMed ID: 28501524
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk Score for Predicting 2-Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi-Trop Cohort Study.
    Di Lorenzo Oliveira C; Nunes MCP; Colosimo EA; de Lima EM; Cardoso CS; Ferreira AM; de Oliveira LC; Moreira CHV; Bierrenbach AL; Haikal DSA; Peixoto SV; Lima-Costa MF; Sabino EC; Ribeiro ALP
    J Am Heart Assoc; 2020 Mar; 9(6):e014176. PubMed ID: 32157953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study.
    Bugge C; Sether EM; Pahle A; Halvorsen S; Sonbo Kristiansen I
    BJGP Open; 2018 Oct; 2(3):bjgpopen18X101596. PubMed ID: 30564729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Containing the Cost of Heart Failure Management: A Focus on Reducing Readmissions.
    Soundarraj D; Singh V; Satija V; Thakur RK
    Card Electrophysiol Clin; 2015 Dec; 7(4):577-84. PubMed ID: 26596803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptide-guided heart failure management.
    Troughton R; Michael Felker G; Januzzi JL
    Eur Heart J; 2014 Jan; 35(1):16-24. PubMed ID: 24216390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol PE; Schroeder-Tanka JM; Voogel AJ; Keijer JT; Kortz RA; Dickhoff C; Meregalli PG; Tijssen JG; Pinto YM; Kok WE
    Am Heart J; 2014 Jul; 168(1):30-6. PubMed ID: 24952857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fall in readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision: a retrospective study.
    Valle R; Aspromonte N; Carbonieri E; D'Eri A; Feola M; Giovinazzo P; Noventa F; Prevaldi C; Barro S; Milani L
    Int J Cardiol; 2008 Jun; 126(3):400-6. PubMed ID: 17804095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure.
    Griffin EA; Wonderling D; Ludman AJ; Al-Mohammad A; Cowie MR; Hardman SMC; McMurray JJV; Kendall J; Mitchell P; Shote A; Dworzynski K; Mant J
    Value Health; 2017 Sep; 20(8):1025-1033. PubMed ID: 28964433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How peptide technology has improved costs and outcomes in patients with heart failure.
    Athanasakis K; Arista I; Balasopoulos T; Boubouchairopoulou N; Kyriopoulos J
    Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):371-82. PubMed ID: 27160541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Containing the Cost of Heart Failure Management: A Focus on Reducing Readmissions.
    Soundarraj D; Singh V; Satija V; Thakur RK
    Heart Fail Clin; 2017 Jan; 13(1):21-28. PubMed ID: 27886926
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.